Including results for nektar investor relations
Search only for nktr investor relations
The Investor Relations website contains information about Nektar Therapeutics's business for stockholders, potential investors, and financial analysts.
Investor Events ; Jan 10, 2024 at 5:15 PM PST. 42nd Annual J.P. Morgan Healthcare Conference. Listen to Webcast. Supporting Materials. View Presentation 3.5 MB.
People also ask
Is Nektar Therapeutics a good buy?
What is the company profile of Nektar Therapeutics?
What is the revenue of Nektar?
Who is the CEO of Nektar Therapeutics?
According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.2. The reported EPS for the same ...
Mar 4, 2024 · PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, ...
Get the latest Nektar Therapeutics (NKTR) stock news and headlines to help you in your trading and investing decisions.
Missing: relations | Show results with:relations
NKTR - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Nektar Therapeutics.
Mar 4, 2024 · ... Earnings Conference Call March 4, 2024 5:00 PM ET. Company Participants. Vivian Wu - Director, Investor Relations and Corporate Affairs Howard ...
Past events on Nektar Therapeutics ; 2023-09-13 11:00 am, Investor & Analyst Meeting ; 2023-08-08 05:00 pm, Q2 2023 Earnings Call ; 2023-08-08 04:15 pm, Q2 2023 ...
Discover real-time Nektar Therapeutics Common Stock (NKTR) stock prices, quotes, historical data, news, and Insights for informed trading and investment ...
Nov 7, 2023 · PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2023.